Update on trials examining effects of night-time blood pressure lowering drug treatment on prevention of cardiovascular disease
Current evidence on benefits of night-time blood pressure (BP) lowering drug treatment on cardiovascular disease (CVD) prevention attributable to the Ambulatory Blood Pressure Monitoring in the Prediction of Cardiovascular Events and Effects of Chronotherapy (MAPEC) trial and Bedtime hypertension tr...
| Main Authors: | , |
|---|---|
| Format: | Journal Article |
| Published: |
2022
|
| Online Access: | http://purl.org/au-research/grants/nhmrc/1111170 http://hdl.handle.net/20.500.11937/93104 |